CD4+ T cells have been described to contribute to anti-tumor immunity through a variety of mechanisms including direct killing of tumor cells, augmenting the tumor microenvironment through local secretion of effector cytokines, and providing help to CD8+ T cells [29–33]. This evidence concerns the gene CD8A and neoplasm.